Public disclosures

PTGX insider disclosures

Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.

Advertisement
More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSourceFollow
PATEL DINESH V PH D

President and CEO · Director · Protagonist Therapeutics, Inc

PTGX

Protagonist Therapeutics, Inc

Gift or transfer
Filing details

SEC transaction code G

Common Stock · Direct ownership · Reported balance after transaction: 522668 · This transaction involves a bona fide gift of securities from the Reporting Person to a relative.

2026-11-192026-11-20

300 shares/units

SEC 4Follow
MOLINA ARTURO MD

Chief Medical Officer · Protagonist Therapeutics, Inc

PTGX

Protagonist Therapeutics, Inc

Sell
Filing details

SEC transaction code S

Common Stock · Direct ownership · Reported balance after transaction: 81397 · SEC code covers open-market or private transactions · Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.

2026-11-162026-11-17

≈ $338,798.70

2,718 shares/units

SEC 4Follow

Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.

Advertisement